What is VKTX's five-year median EV/Sales?

There are not enough weekly readings yet for a five-year median EV/Sales.

Does a low historical rank mean a stock is a buy?

No. The rank compares VKTX only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Viking Therapeutics Inc (VKTX) valuation history

Health Care

$26.86

Latest weekly close · Market cap $3.2B

Viking Therapeutics' EV/Sales is not ranked because its revenue over the last twelve months is too small to compare (as of Oct 30, 2026).

No P/E: earnings over the last twelve months are negative.
No P/S: recent financial data is missing.
No EV/EBITDA: recent financial data is missing.

No EV/Sales chart for VKTX right now

VKTX has no weekly EV/Sales history to chart yet.

EV/Sales

n/mnot ranked

No EV/Sales rank: revenue is too small to compare.

Growth, last 12 months vs the year before

Revenue: n/m
EPS: n/m

Health Care peers on EV/Sales

Each percentile compares a stock with its own last five years.

Compare VKTX with peers

Health Care peers of VKTX on EV/Sales
Stock	EV/Sales	Versus its own history	5-year percentile
ABBVAbbVie	8.9×	Historically high	100
AMGNAmgen	7.7×	Historically high	98
ARWRArrowhead Pharmaceuticals Inc	11.6×	Within its usual range	32
BIIBBiogen	4.2×	Historically high	91
BMRNBioMarin Pharmaceutical Inc	4.3×	Below its usual range	29

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on VKTX

No articles about VKTX yet. How valuation percentiles work

Loading peers and related research…

About this history

What is VKTX's current EV/Sales?: Viking Therapeutics' EV/Sales is not ranked because its revenue over the last twelve months is too small to compare (as of Oct 30, 2026).
What is VKTX's five-year median EV/Sales?: There are not enough weekly readings yet for a five-year median EV/Sales.
Does a low historical rank mean a stock is a buy?: No. The rank compares VKTX only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.